retatrutide glp-1 receptor agonist 10mg — Triple (GLP-1 / GIP / Glucagon) — – Prime Labs A review of an investigational
Description
A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.
What if it doesnt work for me?
Results The first cohort included 36082 GLP-1 receptor agonist users (median follow-up 1.3 years) and 234028 DPP-4 inhibitor users (median follow-up 1.7 years)
Berberine is a plant alkaloid affecting glucose metabolism at the cellular level, while GLP-1 agonists regulate appetite and insulin secretion through hormone signaling
A balanced microbiome environment can help support pathways involved in energy metabolism and appetite regulation
Conclusions We found no signal of disproportionate reporting of an association between GLP-1RA use and SSIBs
